ENOV Enovis Corporation: Operating Margin

Corporate emblem and logo of Enovis Inc. (ENOV)

Enovis Corporation (ENOV) relies on stringent FDA certification and patent protection for its orthopedic instruments, which creates high barriers to entry for competitors. Operating profitability based on EBIT confirms this status, where the value of 3.90 captures the current level of efficiency. The automation of implant production minimizes defects, while the humanitarian profile of the products ensures the company's stable expansion across global markets without geopolitical risks.

ENOV: Enovis Operating Margin 04/28/2023 - 11/20/2026

Enovis Corporation - analytical breakdowns and key metrics (ENOV)

- share price and consensus valuation forecast:
Fundamental company analysis:ENOV, Enovis Corp
Brand item of Enovis Inc.

Operating margin measures the share of profit from core business operations before taxes and debt obligations. For investors, this operating profitability metric serves as an indicator of cost management efficiency. A downward trend on the chart signals rising expenses or falling realized prices. The stability of this figure confirms the resilience of the Enovis Corporation (ENOV) business model. Patent protection for orthopedic systems and software integration in clinics allow the company to maintain margins despite high operating expenses.

Competitors of Enovis Corporation (ENOV)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Integra LifeSciences Corp IART|Operating Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Operating Profitability Margin|IRADIMED Inc. - Operating Sales Margin|Operating Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Operating Margin|Profitability of Operations AxoGen Inc AXGN|SI-BONE (SIBN) - Operating Profitability|Operating Profit Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Operating Margin|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)